[go: up one dir, main page]

MX9203452A - Derivados de 2-(piperidin-1-il)-etanol, su preparacion y su aplicacion en terapeutica. - Google Patents

Derivados de 2-(piperidin-1-il)-etanol, su preparacion y su aplicacion en terapeutica.

Info

Publication number
MX9203452A
MX9203452A MX9203452A MX9203452A MX9203452A MX 9203452 A MX9203452 A MX 9203452A MX 9203452 A MX9203452 A MX 9203452A MX 9203452 A MX9203452 A MX 9203452A MX 9203452 A MX9203452 A MX 9203452A
Authority
MX
Mexico
Prior art keywords
therapeutics
enantiomers
piperidin
ethanol
derivatives
Prior art date
Application number
MX9203452A
Other languages
English (en)
Inventor
Corinne Rousselle
Jonathan Frost
Patrick Landenois
Maria Carmen Renones
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9107936A external-priority patent/FR2678270B1/fr
Priority claimed from FR9107934A external-priority patent/FR2678265B1/fr
Priority claimed from FR9204507A external-priority patent/FR2689891B3/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of MX9203452A publication Critical patent/MX9203452A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Compuesto bajo en forma de isómero puro o de mezcla de dos enantiómeros, de fórmula general (I). Se aplica en terapéutica. La molécula representada por la fórmula general (I) que tiene un átomo de carbono asimétrico los compuestos de la invención pueden existir bajo la forma de enantiómeros puros y de mezcla de enantiómeros. Finalmente, los compuestos de la invención pueden presentarse al estado de bases libres o de sales de adición a loa ácidos farmacéuticamente aceptables. Esas diferentes formas forman parte de la invención.
MX9203452A 1991-06-27 1992-06-26 Derivados de 2-(piperidin-1-il)-etanol, su preparacion y su aplicacion en terapeutica. MX9203452A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9107936A FR2678270B1 (fr) 1991-06-27 1991-06-27 Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.
FR9107934A FR2678265B1 (fr) 1991-06-27 1991-06-27 Derives de 4-(2-phenylethyl)piperidine, leur preparation et leur application en therapeutique.
FR9204507A FR2689891B3 (fr) 1992-04-13 1992-04-13 Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.

Publications (1)

Publication Number Publication Date
MX9203452A true MX9203452A (es) 1994-01-31

Family

ID=27252473

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203452A MX9203452A (es) 1991-06-27 1992-06-26 Derivados de 2-(piperidin-1-il)-etanol, su preparacion y su aplicacion en terapeutica.

Country Status (14)

Country Link
EP (1) EP0524846A1 (es)
JP (1) JPH05186460A (es)
KR (1) KR930000505A (es)
CN (1) CN1069491A (es)
AU (1) AU644296B2 (es)
CA (1) CA2072520A1 (es)
CZ (1) CZ199992A3 (es)
FI (1) FI922979L (es)
HU (1) HUT61743A (es)
IE (1) IE922090A1 (es)
IL (1) IL102334A0 (es)
MX (1) MX9203452A (es)
NO (1) NO922521L (es)
NZ (1) NZ243337A (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994001403A1 (en) * 1992-07-08 1994-01-20 Shell Internationale Research Maatschappij B.V. Piperidine derivatives
PL173618B1 (pl) * 1992-10-30 1998-04-30 Pfizer Związki 6-[2-(4-hydroksy-4-fenylopiperydyno)-1-hydroksypropylo]-3,4-dihydro-2(1H)-chinolonowe
FR2727864B1 (fr) * 1994-12-12 1997-04-04 Synthelabo Utilisation des ligands des sites de liaison peripherique pour les benzodiazepines pour la preparation de medicaments utiles dans le traitement des neuropathies peripheriques
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
WO1999058117A1 (fr) * 1998-05-13 1999-11-18 Sanofi-Synthelabo Utilisation de composes reduisant l'apoptose
FR2778564B1 (fr) * 1998-05-13 2001-07-13 Sanofi Sa Utilisation de composes reduisant l'apoptose
DE69932449T2 (de) 1998-12-18 2007-03-15 Scios Inc., Fremont Agonisten und antagonisten von benzodiazepinrezeptoren des peripheren typs
EP1736474A4 (en) * 2004-04-07 2010-04-21 Kyowa Hakko Kirin Co Ltd piperidine
CN103896835A (zh) * 2014-04-20 2014-07-02 武汉珈瑜科技有限公司 喹啉酮类衍生物及其应用
WO2025198588A1 (en) * 2024-03-20 2025-09-25 Bridgene Biosciences, Inc. Preparation of compound and crystalline forms thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1030415A (zh) * 1987-02-20 1989-01-18 山之内制药株式会社 饱和的杂环碳酰胺衍生物和它的制备方法
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
JP2969359B2 (ja) * 1989-01-13 1999-11-02 武田薬品工業株式会社 環状アミン化合物
FR2644786B1 (fr) * 1989-03-21 1993-12-31 Adir Cie Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
JPH03130263A (ja) * 1989-07-19 1991-06-04 Eisai Co Ltd 光学活性ナフチルエタノール誘導体
FR2668149B1 (fr) * 1990-10-18 1994-09-23 Synthelabo Le 1-(3,4-dihydro-2-oxo-1h-quinolein-6-yl)-2-[4-(2-phenyl-ethyl)piperidin-1-yl]ethanol, sa preparation et son application en therapeutique.

Also Published As

Publication number Publication date
HU9202138D0 (en) 1992-10-28
IE922090A1 (en) 1992-12-30
NO922521D0 (no) 1992-06-26
FI922979A0 (fi) 1992-06-26
NZ243337A (en) 1994-03-25
FI922979A7 (fi) 1992-12-28
KR930000505A (ko) 1993-01-15
CA2072520A1 (en) 1992-12-28
FI922979L (fi) 1992-12-28
HUT61743A (en) 1993-03-01
AU1858992A (en) 1993-01-07
CZ199992A3 (en) 1993-01-13
NO922521L (no) 1992-12-28
AU644296B2 (en) 1993-12-02
IL102334A0 (en) 1993-01-14
JPH05186460A (ja) 1993-07-27
CN1069491A (zh) 1993-03-03
EP0524846A1 (fr) 1993-01-27

Similar Documents

Publication Publication Date Title
MX9203452A (es) Derivados de 2-(piperidin-1-il)-etanol, su preparacion y su aplicacion en terapeutica.
NO20071498L (no) Substituerte acylhydroksamsyrer samt fremgangsmate for a redusere TNFa-nivaet
ES483767A1 (es) Procedimiento para producir n-arilsulfonil-l-argininamidas
ATE104971T1 (de) 2-aminopyrimidinon-derivate.
MX9300256A (es) Derivados de acido acetico y proceso para su preparacion.
FI915136A0 (fi) Cykliska iminoderivat, dessa foereningar innehaollande laekemede och foerfarande foer deras framstaellning.
NO863253L (no) Fremgangsmaate for fremstilling av et vandig vaeskeformig preparat.
AR006360A1 (es) Derivados de 1,2,3,4-tetrahidronaftaleno substituidos, uso de los mismos para la preparacion de medicamentos y procedimiento para su preparacion.
MX3217E (es) Procedimiento para la preparacion de derivados de propoxi -3,4- di hidro carbo estirilo substituidos
BR9503536A (pt) Composto processo para sua preparação seu uso e composição farmacêutica
ES543786A0 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo dietilaminoalcoxi sustituido y sus sales deadicion acidas y amonicas cuaternarias
NO177995C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3-dioksanderivater
ATE131478T1 (de) 4-((2-benzothiazolyl)methylamino>-alpha-(3,4- difluorphenoxy)methyl-1-piperidenethanol
AR018675A1 (es) Derivados de 3-(2-oxo-[1,3¿i¿]bipirrolidinil-3-ilidenometil)-cefem, una composicion farmaceutica y el uso de los mismos para la manufactura de un medicamento.
AR035601A1 (es) Procesos de preparacion de inhibidores del intercambiador de sodio-hidrogeno de tipo 1, inhibidores, sales de dichos compuestos, composiciones farmaceuticas y uso de los mismos en la preparación de medicamentos
DK447284A (da) Aminoderivater af 2-(n-(2,2,5,5-tetramethyl-3-pyrrolin-3-carbonyl)),deres fremstilling og anvendelse
KR920006346A (ko) 3-(1h-인다졸-3-일)-4-피리딘아민, 이의 제조방법, 이의 제조를 위한 중간체 및 약제로서의 이의 용도
SE425395B (sv) Forfarande for framstellning av fenyl- eller bensylfosfonatestrar
KR910014371A (ko) 인돌일프로판올. 이들의 제조방법. 이들의 용도및 이러한 화합물을 함유하는 제제
ES543790A0 (es) Procedimiento de preparacion de nuevos derivados a-etilami- noetoxibencilalcoholicos con un grupo fenil sustituido en situacion a y de sus sales de adicion acidas y amonicas cua-ternarias
ECSP910725A (es) Procedimiento para preparar nuevos derivados de 4( 1h) quinolona
ES422085A1 (es) Procedimiento para preparar amino-acilanilidas primarias.
ES528460A0 (es) Procedimiento de preparacion de nuevos deridados de alfa-etibenzol con un grupo amino propanolico sustituido y sus sales de adicion acidas y amonicas cuaternarias.
AR000267A1 (es)
DK128892A (da) Benzyletherderivater